4 results
Approved WMOCompleted
To investigate if jerks and psychiatric disorders in patients with dystonia are associated with a hyperdopaminergic/ hyposerotonergic system and whether reversal of a hyposerotonergic state has a therapeutic effect.
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
1. Overall survival (primary efficacy endpoint)2a. Efficacy: progression-free survival (PFS), overall response rate (ORR = CR + PR), and a clincal benefit rate (CBR) will be evaluated as CR + PR + SD for at least 3 months.2b. Safety: adverse events…